Sexual dysfunction among early-onset colorectal cancer survivors: Sex-specific correlates of sexual health discussions between patients and providers

Julia Stal(Dana-Farber Cancer Institute), Kimberly A. Miller(University of Southern California), Heinz‐Josef Lenz(University of Southern California), Serena Y Yi(Keck Hospital of USC), Afsaneh Barzi(City Of Hope National Medical Center), Jonathan N. Kaslander(University of Southern California), David R. Freyer(University of Southern California), Sally Cohen‐Cutler(Children's Hospital of Los Angeles), Martina Anto‐Ocrah(University of Pittsburgh), Phuong Gallagher(Army and Navy Club)
Cancer Causes & Control
August 19, 2023
10.1007/s10552-023-01772-1
Cited by 13

Related Papers

Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
|The Lancet Oncology|2017|2.8k
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
|Journal of Clinical Oncology|2018|2.1k
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal Cancer
|JAMA|2017|891
Prognostic and Predictive Relevance of Primary Tumor Location in Patients With <i>RAS </i>Wild-Type Metastatic Colorectal Cancer
|JAMA Oncology|2016|722
Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology Group
|Journal of Clinical Oncology|2012|433